We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Obtains Consent Decree of Permanent Injunction Against Drug Repackager for Alleged CGMP and Labeling Violations

24 September 2013

Focus on Regulation

On September 17, 2013, Judge Algenon L. Marbley of the Southern District of Ohio entered a Consent Decree of Permanent Injunction against Shamrock Medical Solutions Group, LLC (Shamrock), and four of its corporate officers and employees.

Read More: FDA Obtains Consent Decree of Permanent Injunction Against Drug Repackager for Alleged CGMP and Labeling Violations

The team

Loading data